From the AGA Journals
From the AGA Journals
GLP-1s May Increase Post-Endoscopy Aspiration Pneumonia Risk
Additional studies are needed to understand the optimal drug withholding windows before endoscopies and other procedures.
From the AGA Journals
AGA Defines Diagnostic, Treatment Approach to Cannabinoid Hyperemesis Syndrome
Cannabinoid hyperemesis syndrome is triggered by chronic cannabis usage and manifests with GI and autonomic symptoms.
From the AGA Journals
TRAIL-targeting Therapies Still Hold Promise in Cholangiocarcinoma
“Our findings support the role of selective therapeutic targeting of TRAIL-positive cancer cells,” said Dr. Emilien Loeuillard.
From the AGA Journals
IBD: Histologic Inflammation Linked With Lower Female Fertility
In women with clinically quiescent IBD, those with histologic inflammation had significantly reduced fertility, compared with those in histologic...
From the AGA Journals
AGA Clinical Practice Update Describes High-Quality Upper Endoscopy
The update includes best practice advice that addresses procedure optimization, evaluation of suspected premalignancy, and postprocedure follow-up...
From the AGA Journals
Power-Washing Moves Beyond Home Improvement, Into Gastroenterology
Patients with risk of gastric cancer “might be an important group” for evaluating the power-wash procedure, the investigators wrote.
From the AGA Journals
Real-World HDV Study Characterizes Responses to Bulevirtide
The findings suggest that longer follow-up is needed to determine optimal treatment duration for bulevirtide monotherapy.
From the AGA Journals
Computer-Aided Colonoscopy Falls Short in Real-World Practice
CADe-assisted colonoscopy has gained increasing attention for its potential to improve adenoma detection rate.
From the AGA Journals
Liquid Biopsy for Colorectal Cancer Appears Promising But Still Lacks Robust Efficacy
Patients who may have declined colonoscopy should understand the need for a colonoscopy if blood-based tests show abnormal results.
From the AGA Journals
IBS Placebo Responses Predicted By Patient Beliefs, Relationship with Provider
These findings may improve prediction of placebo responses in IBS, and may help avoid patient-provider “mismatch.”